RenovoRx, Inc.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath …
Biotechnology
US, Los Altos [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
RenovoRx, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDRenovoRx, Inc. can't present revenue by segment